Curious to see your top suppliers emissions?
Book a demo for a pilot project
Baiyunshan Wei Ling Pharmaceutical Co., Ltd
Pharmaceutical Preparation ManufacturingChina
Last verified 10 months ago
Baiyunshan Wei Ling Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 1997, the company has established itself as a leader in the development and manufacturing of traditional Chinese medicine and modern pharmaceuticals.
Baiyunshan Wei Ling is renowned for its unique range of herbal products, which combine ancient practices with contemporary scientific research, ensuring efficacy and safety. The company has achieved significant milestones, including numerous certifications and awards that underscore its commitment to quality and innovation.
With a strong market position, Baiyunshan Wei Ling continues to expand its influence in the healthcare sector, providing high-quality solutions that cater to the evolving needs of consumers and healthcare professionals alike.
27
DitchCarbon score
-13 vs industry average
Baiyunshan Wei Ling Pharmaceutical Co., Ltd’s score of 27 is lower than 48% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Baiyunshan Wei Ling Pharmaceutical Co., Ltd?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very High
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Baiyunshan Wei Ling Pharmaceutical Co., Ltd yet.
Baiyunshan Wei Ling Pharmaceutical Co., Ltd's reported carbon emissions
Baiyunshan Wei Ling Pharmaceutical Co., Ltd, headquartered in China (CN), currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, any emissions data or climate commitments would be inherited from this parent company.
At this time, Baiyunshan Wei Ling Pharmaceutical Co., Ltd has not outlined any specific reduction targets or climate pledges. The absence of documented reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy.
As the pharmaceutical industry increasingly focuses on sustainability, it is essential for companies like Baiyunshan Wei Ling to establish clear emissions reduction goals and commitments to align with global climate standards.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Baiyunshan Wei Ling Pharmaceutical Co., Ltd’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Baiyunshan Wei Ling Pharmaceutical Co., Ltd yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Baiyunshan Wei Ling Pharmaceutical Co., Ltd
CNPharmaceutical Preparation Manufacturing10 months ago
27
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more